Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leiv Ose

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Nutrition|November 11, 2003
Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cellsKirsten B Holven, Hanne Scholz, Bente Halvorsen, et al.
Community Genetics|January 17, 2008
Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screeningTrond P Leren, Tora Himle Finborud, Turid E Manshaus, et al.
Metabolism: Clinical and Experimental|August 19, 2007
The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatinSerena Tonstad, Kjetil Retterstøl, Leiv Ose, et al.
Journal of Clinical Lipidology|February 5, 2011
Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemiaEvan A Stein, Leiv Ose, Kjetil Retterstøl, et al.
Clinical Therapeutics|December 26, 2007
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniquesLeiv Ose, Robert Reyes, Amy O Johnson-Levonas, et al.
The British Journal of Nutrition|March 12, 2003
Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjectsKirsten B Holven, Tor S Haugstad, Torbjørn Holm, et al.
European Heart Journal|October 3, 2003
Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and genderKirsten B Holven, Anne M Myhre, Pål Aukrust, et al.
Atherosclerosis|February 10, 2006
Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemiaAgot Lia Amundsen, Janette Khoury, Per Ole Iversen, et al.
Clinical Pharmacology and Therapeutics|June 13, 2006
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathyMonica Hermann, Martin P Bogsrud, Espen Molden, et al.
Journal of Clinical Lipidology|December 22, 2015
Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhoodGisle Langslet, Martin P Bogsrud, Ida Halvorsen, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Nutrition|November 11, 2003
Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cellsKirsten B Holven, Hanne Scholz, Bente Halvorsen, et al.
Community Genetics|January 17, 2008
Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screeningTrond P Leren, Tora Himle Finborud, Turid E Manshaus, et al.
Metabolism: Clinical and Experimental|August 19, 2007
The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatinSerena Tonstad, Kjetil Retterstøl, Leiv Ose, et al.
Journal of Clinical Lipidology|February 5, 2011
Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemiaEvan A Stein, Leiv Ose, Kjetil Retterstøl, et al.
Clinical Therapeutics|December 26, 2007
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniquesLeiv Ose, Robert Reyes, Amy O Johnson-Levonas, et al.
The British Journal of Nutrition|March 12, 2003
Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjectsKirsten B Holven, Tor S Haugstad, Torbjørn Holm, et al.
European Heart Journal|October 3, 2003
Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and genderKirsten B Holven, Anne M Myhre, Pål Aukrust, et al.
Atherosclerosis|February 10, 2006
Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemiaAgot Lia Amundsen, Janette Khoury, Per Ole Iversen, et al.
Clinical Pharmacology and Therapeutics|June 13, 2006
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathyMonica Hermann, Martin P Bogsrud, Espen Molden, et al.
Journal of Clinical Lipidology|December 22, 2015
Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhoodGisle Langslet, Martin P Bogsrud, Ida Halvorsen, et al.
Pageof 8